Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

About Browse conditions ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

Early Stage of Alzheimer's and Parkinson's Diseases, HearIng Relevance (SAPHIR) — Stella

Home/Mild Cognitive Impairment (MCI) Amnestic/Early Stage of Alzheimer's and Parkinson's Diseases, HearIng Relevance (SAPHIR)

View on ClinicalTrials.gov

Recruiting

Back to Mild Cognitive Impairment (MCI) Amnestic trials

Early Stage of Alzheimer's and Parkinson's Diseases, HearIng Relevance (SAPHIR)

Not a traditional drug trial — this study doesn't follow the standard phase structure.

Trial locations(4 sites)

France

CHU Gui de Chauliac, Montpellier

CHU Nice, Nice

CHU Carémeau, Nîmes

Hospices Civils de Lyon, Hôpital des Charpennes, Villeurbanne

Key details

Sponsor

Cilcare SAS

Enrollment target

~309 participants

Started

March 2025

Primary completion

December 2026

Age range

50 Years – 85 Years

Last updated December 2025

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Stella acts as an intermediary. Researcher contact info is never exposed.

Follow this trial

Get notified in plain English when this trial's status changes. No account required.